{
  "DOI": "10.1007/s10689-011-9443-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-011-9443-0",
  "alternative-id": [
    "9443"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Sanchez-Cespedes",
      "given": "Montse",
      "sequence": "first"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        4,
        22
      ]
    ],
    "date-time": "2011-04-22T02:36:09Z",
    "timestamp": 1303439769000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        6,
        10
      ]
    ],
    "date-time": "2019-06-10T02:27:54Z",
    "timestamp": 1560133674000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        12
      ]
    ],
    "date-time": "2024-02-12T16:42:39Z",
    "timestamp": 1707756159670
  },
  "is-referenced-by-count": 43,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2011,
        4,
        23
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2011,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            4,
            23
          ]
        ],
        "date-time": "2011-04-23T00:00:00Z",
        "timestamp": 1303516800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9443-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-011-9443-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9443-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "447-453",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        4,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        4,
        23
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/ijc.1440",
      "author": "DM Parkin",
      "doi-asserted-by": "crossref",
      "first-page": "153",
      "journal-title": "Int J Cancer",
      "key": "9443_CR1",
      "unstructured": "Parkin DM, Bray F, Ferlay J, Pisan P (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153–156",
      "volume": "94",
      "year": "2001"
    },
    {
      "DOI": "10.1093/jnci/83.14.1024",
      "author": "RJC Slebos",
      "doi-asserted-by": "crossref",
      "first-page": "1024",
      "journal-title": "J Natl Cancer Inst",
      "key": "9443_CR2",
      "unstructured": "Slebos RJC, Hruban RH, Dalesio O et al (1991) Relationship between K-ras oncogene activation and smoking in adenocarcinomas of the human lung. J Natl Cancer Inst 83:1024–1027",
      "volume": "83",
      "year": "1991"
    },
    {
      "author": "MS Greenblatt",
      "first-page": "4855",
      "journal-title": "Cancer Res",
      "key": "9443_CR3",
      "unstructured": "Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878",
      "volume": "54",
      "year": "1994"
    },
    {
      "key": "9443_CR4",
      "unstructured": "Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon"
    },
    {
      "DOI": "10.1073/pnas.191502998",
      "author": "A Bhattacharjee",
      "doi-asserted-by": "crossref",
      "first-page": "13790",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9443_CR5",
      "unstructured": "Bhattacharjee A, Richards WG, Staunton J et al (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98:13790–13795",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.241500798",
      "author": "ME Garber",
      "doi-asserted-by": "crossref",
      "first-page": "13784",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9443_CR6",
      "unstructured": "Garber ME, Troyanskaya OG, Schluens K et al (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98:13784–13789",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1002/path.2267",
      "author": "B Angulo",
      "doi-asserted-by": "crossref",
      "first-page": "347",
      "journal-title": "J Pathol",
      "key": "9443_CR7",
      "unstructured": "Angulo B, Suarez-Gauthier A, Lopez-Rios F et al (2008) Expression signatures in lung cancer shows a profile for EGFR-mutant tumors and identifies selective PIK3CA overexpression by gene amplification. J Pathol 214:347–356",
      "volume": "214",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0169-5002(03)00033-3",
      "author": "M Sanchez-Cespedes",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "journal-title": "Lung Cancer",
      "key": "9443_CR8",
      "unstructured": "Sanchez-Cespedes M (2003) Dissecting the genetic alterations involved in lung carcinogenesis. Lung Cancer 40:111–121",
      "volume": "40",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nature07423",
      "author": "L Ding",
      "doi-asserted-by": "crossref",
      "first-page": "1069",
      "journal-title": "Nature",
      "key": "9443_CR9",
      "unstructured": "Ding L, Getz G, Wheeler DA et al (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455:1069–1075",
      "volume": "455",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.21028",
      "author": "R Blanco",
      "doi-asserted-by": "crossref",
      "first-page": "1199",
      "journal-title": "Hum Mutat",
      "key": "9443_CR10",
      "unstructured": "Blanco R, Iwakawa R, Tang M et al (2009) A gene-alteration profile of human lung cancer cell lines. Hum Mutat 30:1199–1206",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa040938",
      "author": "TJ Lynch",
      "doi-asserted-by": "crossref",
      "first-page": "2129",
      "journal-title": "N Engl J Med",
      "key": "9443_CR11",
      "unstructured": "Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 20:2129–2139",
      "volume": "20",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.0405220101",
      "author": "W Pao",
      "doi-asserted-by": "crossref",
      "first-page": "13306",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9443_CR12",
      "unstructured": "Pao W, Miller V, Zakowski M et al (2004) EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306–13311",
      "volume": "101",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1099314",
      "author": "JG Paez",
      "doi-asserted-by": "crossref",
      "first-page": "1497",
      "journal-title": "Science",
      "key": "9443_CR13",
      "unstructured": "Paez JG, Janne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497–1500",
      "volume": "304",
      "year": "2004"
    },
    {
      "DOI": "10.1038/34432",
      "author": "A Hemminki",
      "doi-asserted-by": "crossref",
      "first-page": "184",
      "journal-title": "Nature",
      "key": "9443_CR14",
      "unstructured": "Hemminki A, Markie D, Tomlinson I et al (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 18:184–187",
      "volume": "18",
      "year": "1998"
    },
    {
      "DOI": "10.1038/ng0198-38",
      "author": "DE Jenne",
      "doi-asserted-by": "crossref",
      "first-page": "38",
      "journal-title": "Nat Genet",
      "key": "9443_CR15",
      "unstructured": "Jenne DE, Reimann H, Nezu J et al (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–44",
      "volume": "18",
      "year": "1998"
    },
    {
      "DOI": "10.1056/NEJM198706113162404",
      "author": "FM Giardiello",
      "doi-asserted-by": "crossref",
      "first-page": "1511",
      "journal-title": "N Engl J Med",
      "key": "9443_CR16",
      "unstructured": "Giardiello FM, Welsh SB, Hamilton SR et al (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511–1514",
      "volume": "316",
      "year": "1987"
    },
    {
      "DOI": "10.1038/ajg.2009.725",
      "author": "MG Lier van",
      "doi-asserted-by": "crossref",
      "first-page": "1258",
      "journal-title": "Am J Gastroenterol",
      "key": "9443_CR17",
      "unstructured": "van Lier MG, Wagner A, Mathus-Vliegen EM et al (2010) High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 105:1258–1264",
      "volume": "105",
      "year": "2010"
    },
    {
      "DOI": "10.1002/(SICI)1098-2264(199804)21:4\u003c308::AID-GCC4\u003e3.0.CO;2-2",
      "author": "AK Virmani",
      "doi-asserted-by": "crossref",
      "first-page": "308",
      "journal-title": "Genes Chrom Cancer",
      "key": "9443_CR18",
      "unstructured": "Virmani AK, Fong KM, Kodagoda D et al (1998) Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chrom Cancer 21:308–319",
      "volume": "21",
      "year": "1998"
    },
    {
      "author": "M Sanchez-Cespedes",
      "first-page": "3659",
      "journal-title": "Cancer Res",
      "key": "9443_CR19",
      "unstructured": "Sanchez-Cespedes M, Parrella P, Esteller M et al (2002) Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62:3659–3662",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1038/sj.onc.1207502",
      "author": "J Carretero",
      "doi-asserted-by": "crossref",
      "first-page": "4037",
      "journal-title": "Oncogene",
      "key": "9443_CR20",
      "unstructured": "Carretero J, Medina PP, Pio R et al (2004) Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23:4037–4040",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.onc.1210594",
      "author": "M Sanchez-Cespedes",
      "doi-asserted-by": "crossref",
      "first-page": "7825",
      "journal-title": "Oncogene",
      "key": "9443_CR21",
      "unstructured": "Sanchez-Cespedes M (2007) A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26:7825–7832",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nature06030",
      "author": "H Ji",
      "doi-asserted-by": "crossref",
      "first-page": "807",
      "journal-title": "Nature",
      "key": "9443_CR22",
      "unstructured": "Ji H, Ramsey MR, Hayes DN et al (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448:807–810",
      "volume": "448",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1210418",
      "author": "S Matsumoto",
      "doi-asserted-by": "crossref",
      "first-page": "5911",
      "journal-title": "Oncogene",
      "key": "9443_CR23",
      "unstructured": "Matsumoto S, Iwakawa R, Takahashi K et al (2007) Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26:5911–5918",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6604886",
      "author": "CL Mahoney",
      "doi-asserted-by": "crossref",
      "first-page": "370",
      "journal-title": "Br J Cancer",
      "key": "9443_CR24",
      "unstructured": "Mahoney CL, Choudhury B, Davies H et al (2009) LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Br J Cancer 100:370–375",
      "volume": "100",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.68.4.820",
      "author": "AG Knudson",
      "doi-asserted-by": "crossref",
      "first-page": "820",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9443_CR25",
      "unstructured": "Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823",
      "volume": "68",
      "year": "1971"
    },
    {
      "author": "H Ghaffar",
      "first-page": "2998",
      "journal-title": "Clin Cancer Res",
      "key": "9443_CR26",
      "unstructured": "Ghaffar H, Sahin F, Sanchez-Cespedes M et al (2003) LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res 9:2998–3003",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.humpath.2007.01.022",
      "author": "E Conde",
      "doi-asserted-by": "crossref",
      "first-page": "1351",
      "journal-title": "Hum Pathol",
      "key": "9443_CR27",
      "unstructured": "Conde E, Suarez-Gauthier A, Garcia-Garcia E et al (2007) Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas. Hum Pathol 38:1351–1360",
      "volume": "38",
      "year": "2007"
    },
    {
      "DOI": "10.1086/302159",
      "author": "H Mehenni",
      "doi-asserted-by": "crossref",
      "first-page": "1641",
      "journal-title": "Am J Hum Genet",
      "key": "9443_CR28",
      "unstructured": "Mehenni H, Gehrig C, Nezu J et al (1998) Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet 63:1641–1650",
      "volume": "63",
      "year": "1998"
    },
    {
      "DOI": "10.1093/hmg/8.1.45",
      "author": "A Ylikorkala",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Hum Mol Genet",
      "key": "9443_CR29",
      "unstructured": "Ylikorkala A, Avizienyte E, Tomlinson IP et al (1999) Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet 8:45–51",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1186/1475-4924-2-28",
      "author": "SA Hawley",
      "doi-asserted-by": "crossref",
      "first-page": "28",
      "journal-title": "J Biol",
      "key": "9443_CR30",
      "unstructured": "Hawley SA, Boudeau J, Reid JL et al (2003) Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28",
      "volume": "2",
      "year": "2003"
    },
    {
      "author": "AK Wong",
      "first-page": "6171",
      "journal-title": "Cancer Res",
      "key": "9443_CR31",
      "unstructured": "Wong AK, Shanahan F, Chen Y et al (2000) BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 60:6171–6177",
      "volume": "60",
      "year": "2000"
    },
    {
      "DOI": "10.1002/humu.20730",
      "author": "PP Medina",
      "doi-asserted-by": "crossref",
      "first-page": "617",
      "journal-title": "Hum Mutat",
      "key": "9443_CR32",
      "unstructured": "Medina PP, Romero OA, Kohno T et al (2008) Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat 29:617–622",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1093/carcin/bgp035",
      "author": "S Rodriguez-Nieto",
      "doi-asserted-by": "crossref",
      "first-page": "547",
      "journal-title": "Carcinogenesis",
      "key": "9443_CR33",
      "unstructured": "Rodriguez-Nieto S, Sanchez-Cespedes M (2009) BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. Carcinogenesis 30:547–554",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.96.16.9248",
      "author": "M Tiainen",
      "doi-asserted-by": "crossref",
      "first-page": "9248",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9443_CR34",
      "unstructured": "Tiainen M, Ylikorkala A, Makela TP (1999) Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci USA 96:9248–9251",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1074/jbc.C100207200",
      "author": "P Marignani",
      "doi-asserted-by": "crossref",
      "first-page": "32415",
      "journal-title": "J Biol Chem",
      "key": "9443_CR35",
      "unstructured": "Marignani P, Kanai F, Carpenter CL (2001) LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 276:32415–32418",
      "volume": "276",
      "year": "2001"
    },
    {
      "author": "AI Jimenez",
      "first-page": "1382",
      "journal-title": "Cancer Res",
      "key": "9443_CR36",
      "unstructured": "Jimenez AI, Fernandez P, Dominguez O et al (2003) Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3’-phosphate kinase/PTEN pathway. Cancer Res 63:1382–1388",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S1097-2765(01)00258-1",
      "author": "P Karuman",
      "doi-asserted-by": "crossref",
      "first-page": "1307",
      "journal-title": "Mol Cell",
      "key": "9443_CR37",
      "unstructured": "Karuman P, Gozani O, Odze RD et al (2001) The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7:1307–1319",
      "volume": "7",
      "year": "2001"
    },
    {
      "author": "M Nakau",
      "first-page": "4549",
      "journal-title": "Cancer Res",
      "key": "9443_CR38",
      "unstructured": "Nakau M, Miyoshi H, Seldin MF et al (2002) Hepatocellular carcinoma caused by loss of heterozygosity in lkb1 gene knockout mice. Cancer Res 62:4549–4553",
      "volume": "62",
      "year": "2002"
    },
    {
      "author": "H Miyoshi",
      "first-page": "2261",
      "journal-title": "Cancer Res",
      "key": "9443_CR39",
      "unstructured": "Miyoshi H, Nakau M, Ishikawa TO et al (2002) Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62:2261–2266",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.1062074",
      "author": "A Ylikorkala",
      "doi-asserted-by": "crossref",
      "first-page": "1323",
      "journal-title": "Science",
      "key": "9443_CR40",
      "unstructured": "Ylikorkala A, Rossi DJ, Korsisaari N et al (2001) Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 293:1323–1326",
      "volume": "293",
      "year": "2001"
    },
    {
      "DOI": "10.1093/emboj/cdg292",
      "author": "AF Baas",
      "doi-asserted-by": "crossref",
      "first-page": "3062",
      "journal-title": "EMBO J",
      "key": "9443_CR41",
      "unstructured": "Baas AF, Boudeau J, Sapkota GP et al (2003) Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22:3062–3072",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1093/emboj/cdg490",
      "author": "J Boudeau",
      "doi-asserted-by": "crossref",
      "first-page": "5102",
      "journal-title": "EMBO J",
      "key": "9443_CR42",
      "unstructured": "Boudeau J, Baas AF, Deak M et al (2003) MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22:5102–5114",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1210/en.2003-0982",
      "author": "DG Hardie",
      "doi-asserted-by": "crossref",
      "first-page": "5179",
      "journal-title": "Endocrinology",
      "key": "9443_CR43",
      "unstructured": "Hardie DG (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144:5179–5183",
      "volume": "144",
      "year": "2003"
    },
    {
      "DOI": "10.1101/gad.1199104",
      "author": "MN Corradetti",
      "doi-asserted-by": "crossref",
      "first-page": "1533",
      "journal-title": "Genes Dev",
      "key": "9443_CR44",
      "unstructured": "Corradetti MN, Inoki K, Bardeesy N et al (2004) Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 18:1533–1538",
      "volume": "18",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ccr.2004.06.007",
      "author": "RJ Shaw",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "journal-title": "Cancer Cell",
      "key": "9443_CR45",
      "unstructured": "Shaw RJ, Bardeesy N, Manning BD et al (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6:91–99",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.onc.1209951",
      "author": "J Carretero",
      "doi-asserted-by": "crossref",
      "first-page": "1616",
      "journal-title": "Oncogene",
      "key": "9443_CR46",
      "unstructured": "Carretero J, Medina PP, Blanco R et al (2007) Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene 26:1616–1625",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1207665",
      "author": "P Fernandez",
      "doi-asserted-by": "crossref",
      "first-page": "5084",
      "journal-title": "Oncogene",
      "key": "9443_CR47",
      "unstructured": "Fernandez P, Carretero J, Medina PP et al (2004) Distinctive gene expression of human lung adenocarcinomas carrying LKB1 gene mutations. Oncogene 23:5084–5091",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.emboj.7600110",
      "author": "JM Lizcano",
      "doi-asserted-by": "crossref",
      "first-page": "833",
      "journal-title": "EMBO J",
      "key": "9443_CR48",
      "unstructured": "Lizcano JM, Goransson O, Toth R et al (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23:833–843",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1016/0092-8674(95)90082-9",
      "author": "S Guo",
      "doi-asserted-by": "crossref",
      "first-page": "611",
      "journal-title": "Cell",
      "key": "9443_CR49",
      "unstructured": "Guo S, Kemphues KJ (1995) par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81:611–620",
      "volume": "81",
      "year": "1995"
    },
    {
      "DOI": "10.1038/nature01296",
      "author": "SG Martin",
      "doi-asserted-by": "crossref",
      "first-page": "379",
      "journal-title": "Nature",
      "key": "9443_CR50",
      "unstructured": "Martin SG, St Johnston D (2003) A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 421:379–384",
      "volume": "421",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0092-8674(04)00114-X",
      "author": "AF Baas",
      "doi-asserted-by": "crossref",
      "first-page": "457",
      "journal-title": "Cell",
      "key": "9443_CR51",
      "unstructured": "Baas AF, Kuipers J, van der Wel NN et al (2004) Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116:457–466",
      "volume": "116",
      "year": "2004"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-2989",
      "author": "S Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "740",
      "journal-title": "Cancer Res",
      "key": "9443_CR52",
      "unstructured": "Zhang S, Schafer-Hales K, Khuri FR et al (2008) The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res 68:740–748",
      "volume": "68",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.lungcan.2010.02.004",
      "doi-asserted-by": "crossref",
      "key": "9443_CR53",
      "unstructured": "Roy BC, Kohno T, Iwakawa R et al (2010) Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer. doi: 10.1016/j.lungcan.2010.02.004"
    },
    {
      "author": "J Carretero",
      "first-page": "47",
      "issue": "5",
      "journal-title": "Cancer Cell",
      "key": "9443_CR54",
      "unstructured": "Carretero J, Shimamura T, Rikova K et al (2010) Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17(5):47–59",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1038/onc.2009.453",
      "author": "T Komiya",
      "doi-asserted-by": "crossref",
      "first-page": "1672",
      "journal-title": "Oncogene",
      "key": "9443_CR55",
      "unstructured": "Komiya T, Coxon A, Park Y et al (2010) Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene 29:1672–1680",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1136/bmj.38415.708634.F7",
      "author": "JM Evans",
      "doi-asserted-by": "crossref",
      "first-page": "1304",
      "journal-title": "BMJ",
      "key": "9443_CR56",
      "unstructured": "Evans JM, Donnelly LA, Emslie-Smith AM et al (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304–1305",
      "volume": "330",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-2904",
      "author": "RL Elstrom",
      "doi-asserted-by": "crossref",
      "first-page": "3892",
      "journal-title": "Cancer Res",
      "key": "9443_CR57",
      "unstructured": "Elstrom RL, Bauer DE, Buzzai M et al (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892–3899",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.onc.1208622",
      "author": "M Buzzai",
      "doi-asserted-by": "crossref",
      "first-page": "4165",
      "journal-title": "Oncogene",
      "key": "9443_CR58",
      "unstructured": "Buzzai M, Bauer DE, Jones RG et al (2005) The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24:4165–4173",
      "volume": "24",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-3091",
      "author": "RM Memmott",
      "doi-asserted-by": "crossref",
      "first-page": "580",
      "journal-title": "Cancer Res",
      "key": "9443_CR59",
      "unstructured": "Memmott RM, Gills JJ, Hollingshead M et al (2008) Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells. Cancer Res 68:580–588",
      "volume": "68",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-1362",
      "author": "E Conde",
      "doi-asserted-by": "crossref",
      "first-page": "710",
      "journal-title": "Clin Cancer Res",
      "key": "9443_CR60",
      "unstructured": "Conde E, Angulo B, Tang M et al (2006) Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6 K signaling. Clin Cancer Res 12:710–717",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-08-0213",
      "author": "L Gandhi",
      "doi-asserted-by": "crossref",
      "first-page": "330",
      "journal-title": "Cancer Prev Res",
      "key": "9443_CR61",
      "unstructured": "Gandhi L, McNamara KL, Li D et al (2009) Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis. Cancer Prev Res 2:330–337",
      "volume": "2",
      "year": "2009"
    }
  ],
  "reference-count": 61,
  "references-count": 61,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-011-9443-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The role of LKB1 in lung cancer"
  ],
  "type": "journal-article",
  "volume": "10"
}